Cytokines in autoimmunity: Role in induction, regulation, and treatment

Journal of Interferon and Cytokine Research

Volumn 31, Issue 10, 2011, Pages 695-703

  Moudgil, Kamal D ^a   Choubey, Divaker ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; ENCEPHALOMYELITIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROIDITIS; UVEITIS;

EID: 80054699918     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0065     Document Type: Review

References (103)

1. Abbas AK, Murphy KM, Sher A. 1996. Functional diversity of helper T lymphocytes. Nature 383(6603):787-793. (Pubitemid 26372655)
2. Afzali B, Mitchell P, Lechler RI, John S, Lombardi G. 2010. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol 159(2):120-130.
3. Ahern PP, Schiering C, Buonocore S, McGeachy MJ, Cua DJ, Maloy KJ, Powrie F. 2010. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33(2):279-288.
4. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE. 2007. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13(6):711-718. (Pubitemid 46889754)
5. Ankathatti Munegowda M, Deng Y, Chibbar R, Xu Q, Freywald A, Mulligan SJ, van Drunen Littel-van den Hurk S, Sun D, Xiong S, Xiang J. 2011. A distinct role of CD4(+) Th17-and Th17-stimulated CD8(+) CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis. J Clin Immunol Jun 15 [Epub ahead of print]. DOI: 10.1007/s10875-011-9549-z.
6. Annunziato F, Romagnani S. 2009. Heterogeneity of human effector CD4 + T cells. Arthritis Res Ther 11(6):257.
7. Apostolidis SA, Lieberman LA, Kis-Toth K, Crisṕin JC, Tsokos GC. 2011. The dysregulation of cytokine networks in systemic lupus erythematosus. J Interferon Cytokine Res 31(10): 769-779.
8. Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, Zheng D, Gabrielson K, Iwakura Y, Rose NR, Cihakova D. 2010. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 106(10):1646-1655.
9. Basso AS, Cheroutre H, Mucida D. 2009. More stories on Th17 cells. Cell Res 19(4):399-411.
10. Bending D, De la Pena H, Veldhoen M, Phillips JM, Uyttenhove C, Stockinger B, Cooke A. 2009. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 119(3):565-572.
11. Bettelli E, Korn T, Oukka M, Kuchroo VK. 2008. Induction and effector functions of T(H)17 cells. Nature 453(7198):1051-1057. (Pubitemid 351871737)
12. Bettelli E, Oukka M, Kuchroo VK. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8(4): 345-350. (Pubitemid 46745409)
13. Broderick CA, Smith AJ, Balaggan KS, Georgiadis A, Buch PK, Trittibach PC, Barker SE, Sarra GM, Thrasher AJ, Dick AD, Ali RR. 2005. Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitis. Mol Ther 12(2):369-373. (Pubitemid 41025109)
14. Cao Y, Doodes PD, Glant TT, Finnegan A. 2008. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol 180(2):922-930.
15. Chatenoud L, Bach JF. 2005. Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouse. Int Rev Immunol 24(3-4):247-267. (Pubitemid 40991004)
16. Christen U, Wolfe T, Mohrle U, Hughes AC, Rodrigo E, Green EA, Flavell RA, von Herrath MG. 2001. A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 166(12):7023-7032. (Pubitemid 32525571)
17. Coffman RL. 2006. Origins of the T(H)1-T(H)2 model: a personal perspective. Nat Immunol 7(6):539-541. (Pubitemid 43797329)
18. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DA. 2010. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11(12):1093-1101.
19. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566-569. (Pubitemid 350190247)
20. Cooper WO, Fava RA, Gates CA, Cremer MA, Townes AS. 1992. Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clin Exp Immunol 89(2): 244-250.
21. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wie-kowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421(6924):744-748. (Pubitemid 36227625)
22. Davis LS, Hutcheson J, Mohan C. 2011. The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus. J Interferon Cytokine Res 31(10): 781-789.
23. Dong C. 2011. Genetic controls of Th17 cell differentiation and plasticity. Exp Mol Med 43(1):1-6.
24. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, Njoku DB, Rose NR. 2004. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol 165(6):1883-1894. (Pubitemid 39578368)
25. Fairweather D, Rose NR. 2005. Inflammatory heart disease: a role for cytokines. Lupus 14(9):646-651. (Pubitemid 41413283)
26. Feng G, Gao W, Strom TB, Oukka M, Francis RS, Wood KJ, Bushell A. 2008. Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3 + regulatory T cells. Eur J Immunol 38(9):2512-2527.
27. Feng T, Cao AT, Weaver CT, Elson CO, Cong Y. 2011. Inter-leukin-12 converts Foxp3(+) regulatory T cells to interferon-gamma-producing Foxp3(+) T cells that inhibit colitis. Gas-troenterology 140(7):2031-2043.
28. Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, Gran B, Zhang GX, Rostami A. 2007. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 179(5):3268-3275.
29. Forsthuber T, Yip HC, Lehmann PV. 1996. Induction of TH1 and TH2 immunity in neonatal mice. Science 271(5256):1728-1730.
30. Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS. 2011. Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res 31(10): 721-731.
31. Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, Ramos HL, Wei L, Davidson TS, Bouladoux N, Grainger JR, Chen Q, Kanno Y, Watford WT, Sun HW, Eberl G, Shevach EM, Belkaid Y, Cua DJ, Chen W, O'Shea JJ. 2010. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467(7318):967-971.
32. Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N. 2004. Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J Immunol 173(2):1171-1178. (Pubitemid 38924293)
33. Gu Y, Yang J, Ouyang X, Liu W, Li H, Yang J, Bromberg J, Chen SH, Mayer L, Unkeless JC, Xiong H. 2008. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 38(7):1807-1813.
34. Hall JC, Rosen A. 2010. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol 6(1):40-49.
35. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. 2005. Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6(11):1123-1132. (Pubitemid 41541790)
36. Homann D, von Herrath M. 2004. Regulatory T cells and type 1 diabetes. Clin Immunol 112(3):202-209. (Pubitemid 39078692)
37. Horai R, Caspi RR. 2011. Cytokines in autoimmune uveitis. J Interferon Cytokine Res 31(10):733-744.
38. Horie I, Abiru N, Nagayama Y, Kuriya G, Saitoh O, Ichikawa T, Iwakura Y, Eguchi K. 2009. T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice. Endocrinology 150(11):5135-5142.
39. Horie I, Abiru N, Saitoh O, Ichikawa T, Iwakura Y, Eguchi K, Nagayama Y. 2011. Distinct role of T helper Type 17 immune response for Graves' hyperthyroidism in mice with different genetic backgrounds. Autoimmunity 44(2):159-165.
40. Ivanov, II, Zhou L, Littman DR. 2007. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 19(6):409-417. (Pubitemid 351274050)
41. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, Wilson M, Wynn TA, Kamanaka M, Flavell RA, Sher A. 2007. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204(2):273-283. (Pubitemid 46294544)
42. Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB. 2006. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 103(9):3298-3303. (Pubitemid 43346464)
43. Kalliolias GD, Ivashkiv LB. 2008. IL-27 activates human mono-cytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J Immunol 180(9):6325-6333.
44. Ke Y, Liu K, Huang GQ, Cui Y, Kaplan HJ, Shao H, Sun D. 2009. Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. J Immunol 182(5):3183-3190.
45. Kennedy J, Rossi DL, Zurawski SM, Vega F Jr., Kastelein RA, Wagner JL, Hannum CH, Zlotnik A. 1996. Mouse IL-17: a cytokine preferentially expressed by alpha beta TCR+CD4-CD8-T cells. J Interferon Cytokine Res 16(8):611-617. (Pubitemid 26307020)
46. Kim EY, Chi HH, Bouziane M, Gaur A, Moudgil KD. 2008a. Regulation of autoimmune arthritis by the pro-inflammatory cytokine interferon-gamma. Clin Immunol 127(1):98-106.
47. Kim EY, Chi HH, Rajaiah R, Moudgil KD. 2008b. Exogenous tumour necrosis factor alpha induces suppression of autoimmune arthritis. Arthritis Res Ther 10(1):R38.
48. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. 2005. In-terleukin-32: a cytokine and inducer of TNFalpha. Immunity 22(1):131-142.
49. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Ka-kuta S, Sudo K, Iwakura Y. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalo-myelitis. J Immunol 177(1):566-573. (Pubitemid 43939170)
50. Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB, Oukka M, Kuchroo VK. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448(7152): 484-487. (Pubitemid 47123515)
51. Kunz M, Ibrahim SM. 2009. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoim-munity. Mediators Inflamm 2009:979258.
52. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201(2):233-240. (Pubitemid 40189432)
53. Lee MS, Mueller R, Wicker LS, Peterson LB, Sarvetnick N. 1996. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J Exp Med 183(6):2663-2668. (Pubitemid 26192375)
54. Leishman AJ, Sims GP, Sleeman M, Braddock M. 2011. Emerging small molecule and biological therapeutic approaches for the treatment of autoimmunity. Expert Opin Investig Drugs 20(1):23-39.
55. Leveque L, Deknuydt F, Bioley G, Old LJ, Matsuzaki J, Odunsi K, Ayyoub M, Valmori D. 2009. Interleukin 2-mediated conversion of ovarian cancer-associated CD4 + regulatory T cells into proinflammatory interleukin 17-producing helper T cells. J Immunother 32(2):101-108.
56. Llorente L, Richaud-Patin Y, Garcia-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, Alcocer-Varela J, Grangeot-Keros L, Alarcon-Segovia D, Wijdenes J, Galanaud P, Emilie D. 2000. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43(8):1790-1800.
57. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alco-cer-Varela J, Morel-Fourrier B, Brouet JC, Alarcon-Segovia D, Galanaud P, Emilie D. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181(3):839-844.
58. Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK, Schwarzenberger P, van de Loo FA, van den Berg WB. 2001. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 167(2):1004-1013. (Pubitemid 32660858)
59. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR. 2008. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205(4):799-810. (Pubitemid 351549879)
60. Martin-Orozco N, Chung Y, Chang SH, Wang YH, Dong C. 2009. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 39(1):216-224.
61. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136(7):2348-2357. (Pubitemid 16136806)
62. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317(5835): 256-260. (Pubitemid 47076203)
63. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ. 2003. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198(12): 1951-1957. (Pubitemid 38032126)
64. Murugaiyan G, Mittal A, Weiner HL. 2010. Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation. Proc Natl Acad Sci USA 107(25):11495-11500.
65. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, McInnes IB, Liew FY. 2008. Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 67(10):1474-1479.
66. Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY. 2007. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37(11):3021-3029. (Pubitemid 350131282)
67. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, Schluns K, Tian Q, Watowich SS, Jetten AM, Dong C. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448(7152):480-483. (Pubitemid 47123514)
68. O'Connor W Jr., Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y, Kolls JK, Flavell RA. 2009. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10(6):603-609.
69. O'Garra A, Vieira P. 2007. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7(6): 425-428. (Pubitemid 46834852)
70. O'Shea JJ, Ma A, Lipsky P. 2002. Cytokines and autoimmunity. Nat Rev Immunol 2(1):37-45. (Pubitemid 37328774)
71. Osorio F, Leibund Gut-Landmann S, Lochner M, Lahl K, Spar-wasser T, Eberl G, Reis e Sousa C. 2008. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 38(12):3274-3281.
72. Ouyang W, Kolls JK, Zheng Y. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28(4):454-467. (Pubitemid 351471762)
73. Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, Viatte S, Finckh A, Smith DE, Gabay C. 2009. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 60(3):738-749.
74. Peck A, Mellins ED. 2010. Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 129(2): 147-153.
75. Qin HY, Chaturvedi P, Singh B. 2004. In vivo apoptosis of dia-betogenic T cells in NOD mice by IFN-gamma/TNF-alpha. Int Immunol 16(12):1723-1732. (Pubitemid 40003860)
76. Radhakrishnan S, Cabrera R, Schenk EL, Nava-Parada P, Bell MP, Van Keulen VP, Marler RJ, Felts SJ, Pease LR. 2008. Reprogrammed FoxP3+ T regulatory cells become IL-17 + antigen-specific autoimmune effectors in vitro and in vivo. J Immunol 181(5):3137-3147.
77. Rajaiah R, Puttabyatappa M, Polumuri SK, Moudgil KD. 2011. Interleukin-27 and interferon-gamma are involved in regulation of autoimmune arthritis. J Biol Chem 286(4):2817-2825.
78. Romagnani S. 1997. The Th1/Th2 paradigm. Immunol Today 18(6):263-266. (Pubitemid 27261442)
79. Rose NR. 2011. Critical cytokine pathways to cardiac inflammation. J Interferon Cytokine Res 31(10):705-710.
80. Rose NR, Witebsky E. 1956. Studies on organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J Immunol 76(6): 417-427.
81. Sadelain MW, Qin HY, Lauzon J, Singh B. 1990. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39(5):583-589. (Pubitemid 20223784)
82. Shevach EM. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30(5):636-645.
83. Singh B, Nikoopour E, Huszarik K, Elliott JF, Jevnikar AM. 2011. Immunomodulation and regeneration of islet beta cells by cytokines in autoimmune type 1 diabetes. J Interferon Cyto-kine Res 31(10):711-719.
84. Singh RR, Hahn BH, Sercarz EE. 1996. Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity. J Exp Med 183(4):1613-1621. (Pubitemid 26134303)
85. Sosa RA, Forsthuber TG. 2011. The critical role of antigen-presentation- induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis. J Interferon Cytokine Res 31(10):753-768.
86. Steinman L. 2007. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13(2):139-145.
87. Stockinger B, Veldhoen M. 2007. Differentiation and function of Th17 T cells. Curr Opin Immunol 19(3):281-286. (Pubitemid 46687011)
88. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM. 2008. Differential regulation of central nervous system auto-immunity by T(H)1 and T(H)17 cells. Nat Med 14(3):337-342. (Pubitemid 351347910)
89. Sun L, Louie MC, Vannella KM, Wilke CA, LeVine AM, Moore BB, Shanley TP. 2011. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol 300(3):L341-L353.
90. Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, Wiggert B, Caspi RR. 1999. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med 189(2):219-230. (Pubitemid 29063244)
91. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307-336. (Pubitemid 40563172)
92. van Hamburg JP, Mus AM, de Bruijn MJ, de Vogel L, Boon L, Cornelissen F, Asmawidjaja P, Hendriks RW, Lubberts E. 2009. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis. Arthritis Rheum 60(3):750-759.
93. Veldhoen M, Stockinger B. 2006. TGFbeta1, a "Jack of all trades": the link with pro-inflammatory IL-17-producing T cells. Trends Immunol 27(8):358-361. (Pubitemid 44038659)
94. Villarino AV, Hunter CA. 2004. Biology of recently discovered cytokines: discerning the pro-and anti-inflammatory properties of interleukin-27. Arthritis Res Ther 6(5):225-233. (Pubitemid 40124374)
95. Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ. 2009. Identification of IL-17-producing FOXP3 + regulatory T cells in humans. Proc Natl Acad Sci USA 106(12):4793-4798.
96. Volin MV, Koch AE. 2011. Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis. J Inter-feron Cytokine Res 31(10):745-751.
97. Wang R, Han G, Wang J, Chen G, Xu R, Wang L, Li X, Shen B, Li Y. 2008. The pathogenic role of interleukin-27 in autoimmune diabetes. Cell Mol Life Sci 65(23):3851-3860.
98. Williams RO, Paleolog E, Feldmann M. 2007. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Curr Opin Pharmacol 7(4):412-417. (Pubitemid 47289266)
99. Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B, Kuchroo VK. 2008. Retinoic acid increases Foxp3 + regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181(4):2277-2284.
100. Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR, Pitman N, Kurowska-Stolarska M, McKenzie AN, McInnes IB, Liew FY. 2008. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 105(31): 10913-10918.
101. Yang J, Chu Y, Yang X, Gao D, Zhu L, Yang X, Wan L, Li M. 2009. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 60(5):1472-1483.
102. Zhou L, Chong MM, Littman DR. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30(5):646-655.
103. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453(7192):236-240. (Pubitemid 351667978)